Pharis Biotec GmbH

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pharis Biotec GmbH.The latest application filed is for "protransduzin-d - improved enhancer of gene transfer".

Company Profile

5.9.13

Pharis Biotec GmbH - Hanover DE
PHARIS BIOTEC GMBH - Hannover DE
Pharis Biotec GmbH -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Protransduzin-d - Improved Enhancer Of Gene Transfer App 20210154327 - FORSSMANN; Wolf-Georg ; et al.	2021-05-27
Protransducine-c: Gene Transfer Activator App 20190315816 - FORSSMANN; Wolf-Georg ; et al.	2019-10-17
Peptides with antagonistic activities against natural CXCR4 Grant 10,294,272 - Forssmann , et al.	2019-05-21
Protransduzin B, A Gene Transfer Enhancer App 20190100557 - Forssmann; Wolf-Georg ; et al.	2019-04-04
Protransduzin B, a gene transfer enhancer Grant 10,125,169 - Forssmann , et al. November 13, 2	2018-11-13
Protransduzin B, A Gene Transfer Enhancer App 20160185820 - Forssmann; Wolf-Georg ; et al.	2016-06-30
Polypeptide For The Protection Against Heart Ischemia-reperfusion Injury App 20140336118 - Treiman; Marek ; et al.	2014-11-13
Process For Preparing Human Relaxin-2 App 20140328900 - Forssmann; Wolf-Georg ; et al.	2014-11-06
Composition for the therapy of diabetes mellitus and adiposity App 20140024585 - Forssmann; Wolf Georg ; et al.	2014-01-23
Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments App 20090240031 - Immer; Hansueli ; et al.	2009-09-24
Processed human chemokines PHC-1 and PHC-2 App 20090082262 - Forssman; Wolf-Georg ; et al.	2009-03-26
Composition for the therapy of diabetes mellitus and adiposity App 20080242609 - Forssmann; Wolf Georg ; et al.	2008-10-02
Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same App 20060122371 - Immer; Hansueli ; et al.	2006-06-08
Serine proteinase inhibitors Grant 7,045,594 - Forssmann , et al. May 16, 2	2006-05-16
Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections Grant 7,033,997 - Forssmann , et al. April 25, 2	2006-04-25
Serine proteinase inhibitors Grant 6,939,851 - Forssmann , et al. September 6, 2	2005-09-06
Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections App 20050089514 - Forssmann, Wolf-Georg ; et al.	2005-04-28
Bifidogenic peptides Grant 6,849,593 - Forssmann , et al. February 1, 2	2005-02-01
Use of urodilatin for treating chronic kidney failure with residual kidney functions Grant 6,831,064 - Forssmann , et al. December 14, 2	2004-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.